Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
Arcasoy MO, Jiang X. Arcasoy MO, et al. Br J Haematol. 2005 Jul;130(1):121-9. doi: 10.1111/j.1365-2141.2005.05580.x. Br J Haematol. 2005. PMID: 15982354
Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives.
Arcasoy MO. Arcasoy MO. Clin Cancer Res. 2008 Aug 1;14(15):4685-90. doi: 10.1158/1078-0432.CCR-08-0264. Clin Cancer Res. 2008. PMID: 18676735 Review.
Feasibility of myelosuppressive chemotherapy in psychiatric patients on clozapine: A systematic review of the literature.
Grainger BT, Arcasoy MO, Kenedi CA. Grainger BT, et al. Among authors: arcasoy mo. Eur J Haematol. 2019 Oct;103(4):277-286. doi: 10.1111/ejh.13285. Epub 2019 Jul 17. Eur J Haematol. 2019. PMID: 31257631
Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO, Maun NA, Perez L, Forget BG, Berliner N. Arcasoy MO, et al. Eur J Haematol. 2001 Aug;67(2):77-87. Eur J Haematol. 2001. PMID: 11722594
Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO, Karayal AF. Arcasoy MO, et al. Biochim Biophys Acta. 2005 Apr 15;1740(1):17-28. doi: 10.1016/j.bbadis.2005.03.003. Epub 2005 Apr 1. Biochim Biophys Acta. 2005. PMID: 15878737
Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation.
Laubach JP, Fu P, Jiang X, Salter KH, Potti A, Arcasoy MO. Laubach JP, et al. Among authors: arcasoy mo. Exp Hematol. 2009 Dec;37(12):1411-22. doi: 10.1016/j.exphem.2009.09.009. Epub 2009 Oct 6. Exp Hematol. 2009. PMID: 19815050 Free PMC article.
Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity.
Hardee ME, Rabbani ZN, Arcasoy MO, Kirkpatrick JP, Vujaskovic Z, Dewhirst MW, Blackwell KL. Hardee ME, et al. Among authors: arcasoy mo. Mol Cancer Ther. 2006 Feb;5(2):356-61. doi: 10.1158/1535-7163.MCT-05-0196. Mol Cancer Ther. 2006. PMID: 16505109
Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling.
Hanlon PR, Fu P, Wright GL, Steenbergen C, Arcasoy MO, Murphy E. Hanlon PR, et al. Among authors: arcasoy mo. FASEB J. 2005 Aug;19(10):1323-5. doi: 10.1096/fj.04-3545fje. Epub 2005 Jun 9. FASEB J. 2005. PMID: 15946993
Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia.
Arcasoy MO, Amin K, Chou SC, Haroon ZA, Varia M, Raleigh JA. Arcasoy MO, et al. Clin Cancer Res. 2005 Jan 1;11(1):20-7. Clin Cancer Res. 2005. PMID: 15671524
Erythropoietin and erythropoietin receptor expression in human prostate cancer.
Arcasoy MO, Amin K, Vollmer RT, Jiang X, Demark-Wahnefried W, Haroon ZA. Arcasoy MO, et al. Mod Pathol. 2005 Mar;18(3):421-30. doi: 10.1038/modpathol.3800288. Mod Pathol. 2005. PMID: 15467711
68 results
Jump to page